Rapid mineralocorticoid receptor trafficking

Steroids

Volumn 81, Issue , 2014, Pages 103-108

  Gekle, M ^a   Bretschneider, M ^a   Meinel, S ^a   Ruhs, S ^a   Grossmann, C ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Genomic signaling; Mineralocorticoid receptor; Modulation; Trafficking

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CHAPERONE; DIMER; HEAT SHOCK PROTEIN 90; MINERALOCORTICOID RECEPTOR; SODIUM CHLORIDE; ALDOSTERONE; MINERALOCORTICOID ANTAGONIST;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CELLULAR DISTRIBUTION; CLINICAL EFFECTIVENESS; CYTOSOL; DISSOCIATION; DRUG EFFECT; ELECTROLYTE BALANCE; GENE CONTROL; GLUCOCORTICOID RESPONSE ELEMENT; HEART INJURY; HOMEOSTASIS AND REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; KIDNEY DISEASE; LIGAND BINDING; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN PROCESSING; REVIEW; ANIMAL; DNA RESPONSIVE ELEMENT; GENETICS; METABOLISM; PROTEIN TRANSPORT;

ALDOSTERONE; ANIMALS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; OXIDATIVE STRESS; PROTEIN TRANSPORT; RECEPTORS, MINERALOCORTICOID; RESPONSE ELEMENTS;

EID: 84895520923     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2013.10.016     Document Type: Review

References (55)

1. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators N Engl J Med 341 1999 709 717
2. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, and B. Roniker et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
3. B. Pitt, N. Reichek, R. Willenbrock, F. Zannad, R.A. Phillips, and B. Roniker et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study Circulation 108 2003 1831 1838
4. C.L. Sartorio, D. Fraccarollo, P. Galuppo, M. Leutke, G. Ertl, and I. Stefanon et al. Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction Hypertension 50 2007 919 925
5. E.R. Blasi, R. Rocha, A.E. Rudolph, E.A. Blomme, M.L. Polly, and E.G. McMahon Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats Kidney Int 63 2003 1791 1800
6. C.G. Brilla, and K.T. Weber Mineralocorticoid excess, dietary sodium, and myocardial fibrosis J Lab Clin Med 120 1992 893 901
7. W. Qin, A.E. Rudolph, B.R. Bond, R. Rocha, E.A.G. Blomme, and J.J. Goellner et al. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure Circ Res 93 2003 69 76
8. M.D. Galigniana, A.G. Erlejman, M. Monte, C. Gomez-Sanchez, and G. Piwien-Pilipuk The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events Mol Cell Biol 30 2010 1285 1298
9. I. Hernandez-Diaz, T. Giraldez, M.R. Arnau, V.A.J. Smits, F. Jaisser, and N. Farman et al. The mineralocorticoid receptor is a constitutive nuclear factor in cardiomyocytes due to hyperactive nuclear localization signals Endocrinology 151 2010 3888 3899
10. M. Nishi, H. Ogawa, T. Ito, Ki Matsuda, and M. Kawata Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells. In comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants Mol Endocrinol 15 2001 1077 1092
11. D. Pearce, A. Naray-Fejes-Toth, and G. Fejes-Toth Determinants of subnuclear organization of mineralocorticoid receptor characterized through analysis of wild type and mutant receptors J Biol Chem 277 2002 1451 1456
12. L.I. Gallo, A.A. Ghini, G. Piwien Pilipuk, and M.D. Galigniana Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity Biochemistry 46 2007 14044 14057
13. M.D. Galigniana, G. Piwien Pilipuk, K.C. Kanelakis, G. Buton, and C.P. Lantos Molecular mechanism of activation and nuclear translocation of the mineralocorticoid receptor upon binding of pregnanesteroids Mol Cell Endocrinol 217 2004 167 179
14. C.M. Bamberger, M. Wald, A.M. Bamberger, and H.M. Schulte Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin Mol Cell Endocrinol 131 1997 233 240
15. C. Grossmann, S. Ruhs, L. Langenbruch, S. Mildenberger, N. Str+ñtz, and K. Schumann Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling Chem Biol 19 2012 742 751
16. P. Csermely, T. Schnaider, C. Soti, Z. Prohaszka, and G. Nardai The 90-kDa molecular chaperone family: structure, function, and clinical applications Compr Rev Pharmacol Ther 79 1998 129 168
17. M.D. Galigniana, J.L. Scruggs, J. Herrington, M.J. Welsh, C. Carter-Su, and P.R. Housley et al. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton Mol Endocrinol 12 1998 1903 1913
18. M.D. Galigniana, P.C. Echeverria, A.G. Erlejman, and G. Piwien-Pilipuk Role of molecular chaperones and TPR-domain proteins in the cytoplasmic transport of steroid receptors and their passage through the nuclear pore Nucleus 1 2010 299 308
19. G.M. Wochnik, J.L. Rüegg, G.A. Abel, U. Schmidt, F. Holsboer, and T. Rein FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells J Biol Chem 280 2005 4609 4616
20. R.F. Walther, E. Atlas, A. Carrigan, Y. Rouleau, A. Edgecombe, and L. Visentin et al. A serine/threonine-rich motif is one of three nuclear localization signals that determine unidirectional transport of the mineralocorticoid receptor to the nucleus J Biol Chem 280 2005 17549 17561
21. M. Tanaka, M. Nishi, M. Morimoto, T. Sugimoto, and M. Kawata Imaging analysis of mineralocorticoid receptor and importins in single living cells by using GFP color variants Cell Tissue Res 320 2005 447 453
22. M. Nishi, M. Tanaka, Ki Matsuda, M. Sunaguchi, and M. Kawata Visualization of glucocorticoid receptor and mineralocorticoid receptor interactions in living cells with GFP-based fluorescence resonance energy transfer J Neurosci 24 2004 4918 4927
23. T. Trapp, and F. Holsboer Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action Trends Pharmacol Sci 17 1996 145 149
24. J.G. Savory, G.G. Prefontaine, C. Lamprecht, M. Liao, R.F. Walther, and Y.A. Lefebvre et al. Glucocorticoid receptor homodimers and glucocorticoid- mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces Mol Cell Biol 21 2001 781 793
25. Y. Sun, J. Zhang, L. Lu, S.S. Chen, M.T. Quinn, and K.T. Weber Aldosterone-induced inflammation in the rat heart - role of oxidative stress Am J Pathol 161 2002 1773 1781
26. J.B. Park, and E.L. Schiffrin Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1 Am J Hypertens 15 2002 164 169
27. S. Shibata, S. Mu, H. Kawarazaki, K. Muraoka, Ki Ishizawa, and S. Yoshida et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway J Clin Investig 121 2011 3233 3243
28. S. Shibata, M. Nagase, S. Yoshida, W. Kawarazaki, H. Kurihara, and H. Tanaka et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease Nat Med 14 2008 1370 1376
29. M. Nagase, N. Ayuzawa, W. Kawarazaki, K. Ishizawa, K. Ueda, and S. Yoshida et al. Oxidative stress causes mineralocorticoid receptor activation in rat cardiomyocytes: role of small GTPase Rac1 Hypertension 59 2012 500 506
30. W. Kawarazaki, M. Nagase, S. Yoshida, M. Takeuchi, K. Ishizawa, and N. Ayuzawa et al. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation J Am Soc Nephrol 23 2012 997 1007
31. K. Nagata, K. Obata, J. Xu, S. Ichihara, A. Noda, and H. Kimata et al. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats Hypertension 47 2006 656 664
32. P.L. Hordijk Regulation of NADPH oxidases: the role of rac proteins Circ Res 98 2006 453 462
33. M. Ojeda-Cervantes, J. Barrera-Chimal, J. Alberu, R. Perez-Villalva, L. Morales-Buenrostro, and N.A. Bobadilla Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: a double-blind, randomized pilot study Am J Nephrol 37 2013 481 490
34. A. Di Zhang, C.A. Nguyen Dinh, C. Soukaseum, B. Escoubet, A. Cherfa, and S. Messaoudi et al. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling Hypertension 52 2008 1060 1067
35. 2 modulates GRE-element activation by the human mineralocorticoid receptor in HEK cells Mol Cell Endocrinol 264 2007 35 43
36. G. Piwien-Pilipuk, A. Ayala, A. Machado, and M.D. Galigniana Impairment of mineralocorticoid receptor (MR)-dependent biological response by oxidative stress and aging. Correlation with post-translational modification of MR and decreased ADP-ribosylatable level of elongation factor 2 in kidney cells J Biol Chem 277 2002 11896 11903
37. G. Piwien-Pilipuk, and M.D. Galigniana Oxidative stress induced by l-buthionine-(S, R)-sulfoximine, a selective inhibitor of glutathione metabolism, abrogates mouse kidney mineralocorticoid receptor function Biochim Biophys Acta (BBA) - Mol Cell Res 1495 2000 263 280
38. A. Souque, J. Fagart, B. Couette, and M. Rafestin-Oblin Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor J Steroid Biochem Mol Biol 57 1996 315 321
39. S. Ruhs, N. Strätz, K. Schlör, S. Meinel, S. Mildenberger, and S. Rabe et al. Modulation of transcriptional mineralocorticoid receptor activity by nitrosative stress Free Radical Biol Med 53 2012 1088 1100
40. J.W. Funder RALES, EPHESUS and redox J Steroid Biochem Mol Biol 93 2005 121 125
41. M. Tsugita, Y. Iwasaki, M. Nishiyama, T. Taguchi, M. Shinahara, and Y. Taniguchi et al. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells Life Sci 83 2008 426 432
42. E.S. Alnemri, A.B. Maksymowych, N.M. Robertson, and G. Litwack Overexpression and characterization of the human mineralocorticoid receptor J Biol Chem 266 1991 18072 18081
43. M.D. Galigniana Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases Biochem J 333 1998 555 563
44. N. Marissal-Arvy, M. Lombes, J. Petterson, M.P. Moisan, and P. Mormede Gain of function mutation in the mineralocorticoid receptor of the brown Norway rat J Biol Chem 279 2004 39232 39239
45. C. Le Moellic, A. Ouvrard-Pascaud, C. Capurro, F. Cluzeaud, M. Fay, and F. Jaisser et al. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response J Am Soc Nephrol 15 2004 1145 1160
46. C. Massaad, N. Houard, M. Lombes, and R. Barouki Modulation of human mineralocorticoid receptor function by protein kinase A Mol Endocrinol 13 1999 57 65
47. C. Grossmann, A. Benesic, A.W. Krug, R. Freudinger, S. Mildenberger, and B. Gassner Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions Mol Endocrinol 19 2005 1697 1710
48. N. Faresse, J.J. Vitagliano, and O. Staub Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation FASEB J 26 2012 4373 4382
49. S. Vienchareun, D. Le Menuet, L. Martinerie, M. Munier, L. Pascual-Le Tallec, and M. Lombes The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology Nucl Recept Signal 30 2007 e012
50. L. Pascual-Le Tallec, and M. Lombes The mineralocorticoid receptor: a journey exploring its diversity and specificity of action Mol Endocrinol 19 2005 2211 2221
51. M. Tirard, O.F.X. Almeida, P. Hutzler, F. Melchior, and T.M. Michaelidis Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor Mol Cell Endocrinol 268 2007 20 29
52. L. Pascual-Le Tallec, O. Kirsh, M.C. Lecomte, S. Viengchareun, M.C. Zennaro, and A. Dejean et al. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification Mol Endocrinol 17 2003 2529 2542
53. D. Nagata, M. Takahashi, K. Sawai, T. Tagami, T. Usui, and A. Shimatsu et al. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity Hypertension 48 2006 165 171
54. S. Nakano, N. Kobayashi, K. Yoshida, T. Ohno, and H. Matsuoka Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats Hypertens Res 28 2005 925 936
55. S. Stas, A. Whaley-Connell, J. Habibi, L. Appesh, M.R. Hayden, and P.R. Karuparthi et al. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling Endocrinology 148 2007 3773 3780